When the serum phosphate level does not increase in pre-dialysis CKD patients, it is likely that the pathophysiology of CKD-MBD described earlier, which includes increases in FGF23 level and downregulation of αKlotho (although it is difficult to prove clinically), has already begun. This evidence concerns the gene FGF23 and chronic kidney disease.